Today: 19 May 2026
Browse Category

LSE:3IN 5 December 2025 - 2 February 2026

UK stock market today: FTSE 100 steadies as miners tumble in metals rout, BoE looms

UK stock market today: FTSE 100 steadies as miners tumble in metals rout, BoE looms

FTSE 100 edged up 0.1% by late morning as defensive shares offset sharp losses in mining stocks. Commodity prices tumbled after President Trump nominated Kevin Warsh as Fed chair, with gold down 5% and silver over 7%. FTSE 250 fell 0.4%, led by declines in Auction Technology Group and Ocado. UK manufacturing PMI rose to 51.8 in January, signaling growth.
2 February 2026
·············
3i Group plc (LON: III) Stock: Action Jitters, New Lows and Big Upside Targets – Latest News & Forecasts as of 5 December 2025

3i Group plc (LON: III) Stock: Action Jitters, New Lows and Big Upside Targets – Latest News & Forecasts as of 5 December 2025

3i Group shares closed at 3,153p on 4 December 2025, down about 16% over 12 months and 30% below their October peak, after concerns about key asset Action triggered a sharp sell-off. The company’s market cap stands near £30 billion, with a trailing dividend yield of 2.3%. Analysts’ average price targets imply potential gains of 40–45% from current levels.
5 December 2025
··

Stock Market Today

  • When Will Island Pharmaceuticals Limited (ASX:ILA) Reach Profitability?
    May 19, 2026, 3:26 AM EDT. Island Pharmaceuticals Limited (ASX:ILA), a drug repurposing company focusing on antiviral therapeutics in Australia and the U.S., posted a AU$3.9 million loss in the latest financial year and a AU$7.2 million loss over the trailing twelve months. Analysts project the company will break even in 2027 and reach a profit of AU$295 million by 2028. This forecast implies an ambitious average annual growth rate of 140%. Notably, Island Pharmaceuticals operates with no debt, relying solely on shareholder funding, which reduces financial risk typical in cash-burning pharmaceutical firms. Investors anticipate milestone developments but should remain cautious of the high growth assumptions given the volatile nature of pharmaceutical cash flows during drug development phases.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Why Plug Power Stock Is Falling Today After Its Hydrogen Rally

Why Plug Power Stock Is Falling Today After Its Hydrogen Rally

18 May 2026
Plug Power shares dropped 9.8% to $3.41 in late-morning trading Monday, erasing part of last week’s post-earnings rally. The company reported first-quarter revenue of $163.5 million and improved margins, but posted a net loss of $245.3 million. Investors remain concerned about cash burn and future dilution. Other hydrogen stocks also fell sharply.
Go toTop